ESEspen E. Spangenburg

Espen E. Spangenburg

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Espen E. Spangenburg has a total of 121 co-authors. Here are the top co-authors by number of shared publications:

  • Adam J. Amorese

    Department of Physiology, Brody School of Medicine, East Carolina University, Greenville, North Carolina

    5 shared publications
  • Joseph M. McClung

    Department of Physiology, East Carolina University Brody School of Medicine, Greenville, NC, United States

    5 shared publications
  • Michael D. Tarpey

    Department of Physiology, Brody School of Medicine

    4 shared publications
  • Nicholas P. Balestrieri

    Department of Physiology, Brody School of Medicine, East Carolina University, Greenville, North Carolina

    4 shared publications
  • Ana P. Valencia

    School of Public Health, Department of Kinesiology, University of Maryland, College Park, MD, USA

    3 shared publications
  • Dawn A. Lowe

    Division of Rehabilitation Science, Department of Rehabilitation Medicine, Medical School, University of Minnesota, Minneapolis, Minnesota

    3 shared publications

Latest Publications

  • Open Access

    Skeletal muscle carnitine-acylcarnitine translocase deletion reveals vulnerability of oxidative muscle to fatty acid oxidation deficiency

    by Filip Jevtovic, Nicholas C. Williamson, Andrea S. Pereyra, Molly K. Alexander, Espen E. Spangenburg, Jessica M. Ellis

    Novel model of CACT loss in muscle to demonstrate that CACT is required for long, medium, and short-chain fatty acid oxidation in skeletal muscle. Deletion of CACT drives oxidative and glycolytic muscle lipid remodeling and impairs oxidative, but not glycolytic, muscle contractile capacity. Oxidative soleus muscle mitochondria compensate for CACT loss by increasing mitochondrial content and muscle capacity for oxidation of nonfatty acid substrates.


  • Donepezil treatment, alone or combined with exercise, enhances skeletal muscle function in healthy and advanced aging disease mouse models

    by Nicholas J. Ernst, Edziu Franczak, Julie Allen, Everett C. Minchew, Andrew T. Readyoff, Miles C. Farlow, Espen E. Spangenburg, Benjamin F. Miller, Jill K. Morris, Kartik Shankar, et al.

    Aging is often accompanied by a decline in muscle mass and function, with limited effective treatments. The study provides novel insights into the potential of donepezil, an acetylcholinesterase medication primarily used for dementia, to improve skeletal muscle health and function.


  • Ablation of skeletal muscle estrogen receptor alpha impairs contractility in male mice

    by Brian P. Sullivan, Brittany C. Collins, Shawna L. McMillin, Elise Toussaint, Clara Z. Stein, Espen E. Spangenburg, Dawn A. Lowe

    We comprehensively measured in vitro and in vivo contractility of leg muscles with reduced estrogen receptor α (ERα) in male mice and reported that force generation and contraction kinetics are impaired. In contrast to findings in females, phosphorylation of myosin regulatory light chain cannot account for low force production in male skeletal muscle ERα knockout mice. These results indicate that ERα is required for optimal contractility in males and females but via sexually dimorphic means.


  • Open Access

    Hypoxia Resistance Is an Inherent Phenotype of the Mouse Flexor Digitorum Brevis Skeletal Muscle

    by Adam J Amorese, Everett C Minchew, Michael D Tarpey, Andrew T Readyoff, Nicholas C Williamson, Cameron A Schmidt, Shawna L McMillin, Emma J Goldberg, Zoe S Terwilliger, Quincy A Spangenburg, et al.

    The various functions of skeletal muscle (movement, respiration, thermogenesis, etc.) require the presence of oxygen (O2). Inadequate O2 bioavailability (ie, hypoxia) is detrimental to muscle function and, in chronic cases, can result in muscle wasting. Current therapeutic interventions have proven largely ineffective to rescue skeletal muscle from hypoxic damage. However, our lab has identified a mammalian skeletal muscle that maintains proper physiological function in an environment depleted of O2. Using mouse models of in vivo hindlimb ischemia and ex vivo anoxia exposure, we observed the preservation of force production in the flexor digitorum brevis (FDB), while in contrast the extensor digitorum longus (EDL) and soleus muscles suffered loss of force output. Unlike other muscles, we found that the FDB phenotype is not dependent on mitochondria, which partially explains the hypoxia resistance. Muscle proteomes were interrogated using a discovery-based approach, which identified significantly greater expression of the transmembrane glucose transporter GLUT1 in the FDB as compared to the EDL and soleus. Through loss-and-gain-of-function approaches, we determined that GLUT1 is necessary for the FDB to survive hypoxia, but overexpression of GLUT1 was insufficient to rescue other skeletal muscles from hypoxic damage. Collectively, the data demonstrate that the FDB is uniquely resistant to hypoxic insults. Defining the mechanisms that explain the phenotype may provide insight towards developing approaches for preventing hypoxia-induced tissue damage.


  • Open Access

    Challenging Dogma about Myonuclei Behavior in Skeletal Muscle Cells

    by Espen E Spangenburg

    Espen E Spangenburg, PhD; Challenging dogma about myonuclei behavior in skeletal muscle cells, Function, , zqac068, https://doi.org/10.1093/function/zqac068

  • Open Access

    Isometric skeletal muscle contractile properties in common strains of male laboratory mice

    by Everett C. Minchew, Nicholas C. Williamson, Andrew T. Readyoff, Joseph M. McClung, Espen E. Spangenburg

    Assessing contractile function of skeletal muscle in murine models is a commonly employed laboratory technique that investigators utilize to measure the impact of genetic manipulations, drug efficacy, or other therapeutic interventions. Often overlooked is the potential for the strain of the mouse to influence the functional properties of the skeletal muscle. Thus, we sought to characterize commonly assessed isometric force measures in the hindlimb muscles across a variety of mouse strains. Using 6-8-week-old male mice, we measured isometric force, fatigue susceptibility, relaxation kinetics, muscle mass, myofiber cross-sectional area, and fiber type composition of the extensor digitorum longus (EDL) and soleus muscles in C57BL/6NJ, BALB/cJ, FVB/NJ, C57BL/6J, and C57BL/10 mice. The data demonstrate both unique differences and a number of similarities between both muscles in the various genetic backgrounds of mice. Soleus muscle specific force (i.e., force per unit size) exhibited higher variation across strains while specific force of the EDL muscle exhibited minimal variation. In contrast, absolute force differed only in a few mouse strains whereas analysis of muscle morphology revealed many distinctions when compared across all the groups. Collectively, the data suggest that the strain of the mouse can potentially influence the measured biological outcome and may possibly promote a synergistic effect with any genetic manipulation or therapeutic intervention. Thus, it is critical for the investigator to carefully consider the genetic background of the mouse used in the experimental design and precisely document the strain of mouse employed during publication.


  • Extracellular vesicle secretion is tissue-dependent ex vivo and skeletal muscle myofiber extracellular vesicles reach the circulation in vivo

    by Andrea L. Estrada, Zackary J. Valenti, Gabriella Hehn, Adam J. Amorese, Nicholas S. Williams, Nicholas P. Balestrieri, Clayton Deighan, Christopher P. Allen, Espen E. Spangenburg, Nicole A. Kruh-Garcia, et al.

    Extracellular vesicles (EVs) are biomarkers and modifiers of human disease. EVs secreted by insulin-responsive tissues like skeletal muscle (SkM) and white adipose tissue (WAT) contribute to metabolic health and disease but the relative abundance of EVs from these tissues has not been directly examined. Human Protein Atlas data and directly measuring EV secretion in mouse SkM and WAT using an ex vivo tissue explant model confirmed that SkM tissue secretes more EVs than WAT. Differences in EV secretion between SkM and WAT were not due to SkM contraction but may be explained by differences in tissue metabolic capacity. We next examined how many EVs secreted from SkM tissue ex vivo and in vivo are myofiber-derived. To do this, a SkM myofiber-specific dual fluorescent reporter mouse was created. Spectral flow cytometry revealed that SkM myofibers are a major source of SkM tissue-derived EVs ex vivo and EV immunocapture indicates that ∼5% of circulating tetraspanin-positive EVs are derived from SkM myofibers in vivo. Our findings demonstrate that 1) SkM secretes more EVs than WAT, 2) many SkM tissue EVs are derived from SkM myofibers, and 3) SkM myofiber-derived EVs reach the circulation in vivo. These findings advance our understanding of EV secretion between metabolically active tissues and provide direct evidence that SkM myofibers secrete EVs that can reach the circulation in vivo.


  • Skeletal muscle wasting: the estrogen side of sexual dimorphism

    by Shawna L. McMillin, Everett C. Minchew, Dawn A. Lowe, Espen E. Spangenburg

    The importance of defining sex differences across various biological and physiological mechanisms is more pervasive now than it has been over the past 15–20 years. As the muscle biology field pushes to identify small molecules and interventions to prevent, attenuate, or even reverse muscle wasting, we must consider the effect of sex as a biological variable. It should not be assumed that a therapeutic will affect males and females with equal efficacy or equivalent target affinities under conditions where muscle wasting is observed. With that said, it is not surprising to find that we have an unclear or even a poor understanding of the effects of sex or sex hormones on muscle wasting conditions. Although recent investigations are beginning to establish experimental approaches that will allow investigators to assess the impact of sex-specific hormones on muscle wasting, the field still needs rigorous scientific tools that will allow the community to address critical hypotheses centered around sex hormones. The focus of this review is on female sex hormones, specifically estrogens, and the roles that these hormones and their receptors play in skeletal muscle wasting conditions. With the overall review goal of assembling the current knowledge in the area of sexual dimorphism driven by estrogens with an effort to provide insights to interested physiologists on necessary considerations when trying to assess models for potential sex differences in cellular and molecular mechanisms of muscle wasting.


  • Open Access

    Can the Energetic Profile of Skeletal Muscle Predict Risk of Cognitive Impairment?

    by Espen E Spangenburg

    Alzheimer's disease (ad) is one of the most common neurodegenerative disorders that affects memory, thinking, and behavior, as humans age. ad is a complex, multifactorial condition that lacks many treatment options from a clinical perspective. Further complicating treatment of AD is the presence of other secondary issues such as peripheral insulin resistance, low physical activity, high blood pressure, obesity, and so on. Thus, clinicians are tasked with diagnosing patients without proven basic scientific analytical tools while the patient is presenting with other clinical issues.

  • Skeletal Muscle Function Is Dependent Upon BRCA1 to Maintain Genomic Stability

    by Michael D. Tarpey, Adam J. Amorese, Elizabeth R. LaFave, Everett C. Minchew, Kelsey H. Fisher-Wellman, Joseph M. McClung, Eli G. Hvastkovs, Espen E. Spangenburg

    Breast Cancer gene 1 (BRCA1) is a large, multifunctional protein that regulates a variety of mechanisms in multiple different tissues. Our work established that Brca1 is expressed in skeletal muscle and localizes to the mitochondria and nucleus. Here, we propose BRCA1 expression is critical for the maintenance of force production and mitochondrial respiration in skeletal muscle.